| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |